osteosarcoma

Okay, we'll move on to the next paper.

I'll be discussing Enhancing Osteosarcoma Survival Predictions, a Comparative Study of a Multi-Component Model Machine Learning Approach Integrating SEER and NCDB Datasets Versus Conventional Single Dataset Modeling by Goloa.

And there is a commentary.

So this study was performed at the Massachusetts General Hospital by my friend and colleague, Dr. Santiago Lozano Calderon, as the senior author.

The study seeks to address the shortcomings of machine learning for prognostication in osteogenic sarcoma.

Osteosarcoma, as many know, is the most common primary bone tumor in adults, adolescents, and children.

There's a bimodal age distribution.

It has a five-year survival rate of 60% to 70%, and only 15% to 30% in metastatic cases.